Senior insider sale
EVP, Chief Legal Officer at ASCENDIS PHARMA A/S — senior position signals high conviction
$6.52M
28.35K shares
What this filing means
JENSEN MICHAEL WOLFF plans to sell 28.35K shares of ASCENDIS PHARMA A/S valued at approximately $6.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001973379-26-000062
Officer· EVP, Chief Legal Officer
Since Mar 2026
28.35K
Shares to sell
$6.52M
Approx. market value
18.35K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RESTRICTED STOCK VESTING
COMPENSATION
3/2/2026
18.35KTotal acquired18.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | RESTRICTED STOCK VESTING COMPENSATION | 18.35K | — |
| Total | 18.35K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$2.08M
12/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.35K
Market value
$4.44M
3/2/2026
Total
Units
28.35K
Value
$6.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/4/2025 | 10K | $2.08M | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 18.35K | $4.44M | NASDAQ | Planned |
| Total | 28.35K | $6.52M | ||